Private Equity

Accelerating value creation and technology adoption

Acquis partners with private equity firms to accelerate value creation by integrating strategy, technology enablement, and execution across their entire investment portfolios.

Our teams operate at both the fund and portfolio company levels — supporting investment theses, driving operational improvements, and enabling technology adoption. This hands-on, integrated approach delivers measurable impact, shortens value creation timelines, and enhances portfolio performance.

Private equity fund managers face significant market forces

Increasing valuations

With record dry powder and increasing entry multiples, unlocking value has become exceedingly difficult

Increasing competition

With new funds entering the market, unlocking and creating value is more difficult than ever

The need for transformation

With deal success hinging on fast alignment, transformation is often the difference between a thesis on paper and value in practice.

Regulatory changes

As private markets continue to represent a higher proportion of assets under management, new regulatory pressures create increasing complexity.

Increasing valuations

With record dry powder and increasing entry multiples, unlocking value has become exceedingly difficult

Increasing competition

With new funds entering the market, unlocking and creating value is more difficult than ever

The need for transformation

With deal success hinging on fast alignment, transformation is often the difference between a thesis on paper and value in practice.

Regulatory changes

As private markets continue to represent a higher proportion of assets under management, new regulatory pressures create increasing complexity.

Accelerating value creation timelines with hands-on execution

Acquis' principal investors and private equity consultants partner with some of the world’s most influential private equity firms — from leading megacap investors to first-time funds. At the core of our private equity practice is a deep understanding of deal flow and value creation that drives measurable results.

100-Day Sprint

Helping clients develop and execute aggressive, targeted plans of action for the first 100 days post-close to capture near-term opportunities.

IPO Readiness

Support overall IPO planning and management of the process to reduce risk to timeline.

Platform Creation

Help consolidating and establishing a platform operating model to enable scalability and bolt on acquisitions.

Technology Implementation

Blending technical and business process-oriented subject matter expertise to enrich and accelerate the technology implementation.

Technology Strategy

Selecting the right tools and systems to accelerate impact.

Value Capture

Improve margins through cost improvement, efficiency.

Impact throughout the investment lifecycle

Quick, tangible value capture results

Acquis’ unique approach of Think+Do allows us to rapidly achieve real results that impact the bottom line.

Jump start day 1

We mobilize and accelerate readiness to support day 1 through to day 100.

Platform growth is our specialty

We know how to scale and consolidate to enable platform operating model level transformation growth.

For nearly 30 years, Acquis has helped private equity general partners create and unlock value across their portfolios throughout the investment lifecycle.

Featured client stories

Case Study
The Missing “E” in T&E: Concur Expense Success Story
Acquis helped a global investment firm solve for the missing "E" in T&E by implementing Concur Expense alongside its existing Concur Travel module.
Read More
Case Study
Providing Divestiture Support
After the decision to simultaneously spin-off two major divisions, a leading pharmaceutical company experienced overwhelming divestiture activities.
Read More

Case Study

The Missing “E” in T&E: Concur Expense Success Story

Acquis helped a global investment firm solve for the missing "E" in T&E by implementing Concur Expense alongside its existing Concur Travel module.

Case Study

Providing Divestiture Support

After the decision to simultaneously spin-off two major divisions, a leading pharmaceutical company experienced overwhelming divestiture activities.

Article
Post-Merger Integration: Maximizing Value in Pharmaceutical M&A Deals
Despite recent economic volatility, mergers and acquisitions (M&A) remain a prevailing strategy in today’s global market for corporations seeking to rapidly increase shareholder value and bottom-line growth.
Read More
Article
The Evolving Landscape of Business Strategy: Navigating New Realities
The VIX index has averaged above 20 in recent years, compared to historical averages of 15-17, forcing leaders to reconsider their approach to everything from strategic trade-offs around capital allocation and tech investments to evolving operating models.
Read More
Article
Optimizing Procurement Strategy in the Face of Rising U.S. Tariffs
The growing prevalence and fluidity of protectionism and tariffs across the globe mean that a proactive procurement strategy is no longer optional — it is essential for business survival and competitive advantage.
Read More

Article

Post-Merger Integration: Maximizing Value in Pharmaceutical M&A Deals

Despite recent economic volatility, mergers and acquisitions (M&A) remain a prevailing strategy in today’s global market for corporations seeking to rapidly increase shareholder value and bottom-line growth.

Article

The Evolving Landscape of Business Strategy: Navigating New Realities

The VIX index has averaged above 20 in recent years, compared to historical averages of 15-17, forcing leaders to reconsider their approach to everything from strategic trade-offs around capital allocation and tech investments to evolving operating models.

Article

Optimizing Procurement Strategy in the Face of Rising U.S. Tariffs

The growing prevalence and fluidity of protectionism and tariffs across the globe mean that a proactive procurement strategy is no longer optional — it is essential for business survival and competitive advantage.

Ready to learn more?

Get in touch with the Acquis team to unlock alpha

Get Started